In this episode, host Etienne Nichols and guest Dr. Allison Komiyama, CEO and Founder of Blue Stocking Health, dive into a fascinating dialogue about the language used in healthcare and MedTech, particularly the terms patient, customer, and user. They explore how these words influence the perception of care, service, and the entire medical device development process. The conversation touches on the friction and inefficiencies that arise when the relationship dynamic is unclear, highlighting the different nuances between passively receiving treatment and being an active consumer of health services.

The discussion delves into the historical context of the word "patient," which is rooted in the Latin patior, meaning 'to suffer.' Dr. Komiyama shares insights from industry conferences, noting that many individuals prefer to be called a "person" or an "empowered patient" rather than a passive sufferer. This ties directly into the growing movement of individuals seeking to own their health and be active participants in their care, fueled by readily available information and a focus on health span over just disease treatment.

Ultimately, the key takeaway for MedTech innovators is the importance of understanding their end-user and tailoring their language—in labeling, clinical studies, and human factors testing—to align with the user's preferred terminology. The shift from "caregiver" to "care partner" is highlighted as a prime example of evolving language that acknowledges a collaborative, mutual relationship, moving away from a hierarchical structure to one of shared purpose.

Key Timestamps

[0:01:25] - Introduction to Dr. Allison Komiyama and Blue Stocking Health's mission to amplify the good of MedTech.
[0:04:14] - Discussion begins: Patient vs. Customer vs. User in MedTech.
[0:06:05] - The etymology of "patient" (patior, to suffer) and the push for "person" or "empowered patient."
[0:08:22] - Historical context: Passivity of the patient role and the doctor's assumed knowledge.
[0:09:50] - The impact of consumerism, AI, and the "health span" movement on patient empowerment.
[0:12:35] - The value of seeking multiple opinions and the role of patient priorities in customizing care.
[0:15:30] - Shifting terminology: Why "caregiver" is moving toward "care partner."
[0:18:22] - How language diversity enriches the conversation and enhances communication.
[0:21:00] - Tying diverse language use to MedTech innovation and product development.
[0:22:15] - The importance of understanding end-user biases and assumptions in MedTech.
[0:24:25] - Impactful personal stories: How specific interactions define a positive care experience.
[0:29:10] - Concluding thoughts: Why plurality and qualifiers (e.g., "empowered patient") may be the ideal goal.

Quotes

"I think there's a lot of folks at FDA even that we're like, we don't want to use the word patient. We want to use the word person. And patient actually comes from the term patior, which means to suffer." - Dr. Allison Komiyama

Takeaways

Regulatory & Clinical Strategy: When defining the target population for your device—in 510k, IDE, or PMA submissions—be mindful of the terminology. Consider using terms like "end-user," "person living with [condition]," or "care partner" alongside "patient" to reflect a modern, inclusive understanding of...

#430: MedTech Language: Patient, Customer, or Partner?

Global Medical Device Podcast powered by Greenlight Guru